Clinical Trial Update: OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting [NA]

View source ↗

Summary

This completed clinical trial evaluated the use of OIF combined with beta-tricalcium phosphate (β-TCP) as a bone grafting material for open tibial fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open Fracture of Tibia

Drugs mentioned

• OIF/β-TCP

Snippet

Sponsor: BioGend Therapeutics Co.Ltd | Conditions: Tibia Fracture | NA | Status: COMPLETED